title: A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.
abstract: Tobacco addiction is characterized by a lack of control over smoking and relapse after periods of abstinence. Smoking cessation leads to a dysphoric state that contributes to relapse to smoking. After the acute withdrawal phase, exposure to stressors increases the risk for relapse. Blockade of melanocortin 4 (MC4 ) receptors has anxiolytic and antidepressant-like effects in animal models. The aim of these studies was to investigate the role of MC4 receptors in the dysphoria associated with nicotine withdrawal and stress-induced reinstatement of nicotine seeking. To study stress-induced reinstatement, rats self-administered nicotine for 16 days and then nicotine seeking was extinguished by substituting saline for nicotine. Nicotine seeking was reinstated by intermittent footshock stress. The intracranial self-stimulation (ICSS) procedure was used to assess the negative mood state associated with nicotine withdrawal. Elevations in the ICSS thresholds are indicative of a dysphoric state. The selective MC4 receptor antagonists HS014 and HS024 prevented stress-induced reinstatement of extinguished nicotine seeking. Drug doses that prevented stress-induced relapse did not affect responding for food pellets, which indicates that the drugs did not induce sedation or motor impairments. In the ICSS experiments, the nicotinic acetylcholine receptor antagonist mecamylamine elevated the ICSS thresholds of the nicotine-dependent rats. Pre-treatment with HS014 or HS024 did not prevent the elevations in ICSS thresholds. These studies indicate that MC4 receptors play a critical role in stress-induced reinstatement of nicotine seeking, but these receptors may not play a role in the dysphoria associated with acute nicotine withdrawal.
authors.affiliation: Department of Psychiatry, McKnight Brain Institute, University of Florida, Gainesville, FL, USA.
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Qi
authors.forename: Hidetaka
authors.initials: H
authors.lastname: Yamada
authors.forename: Lu W
authors.initials: LW
authors.lastname: Corrie
authors.forename: Yue
authors.initials: Y
authors.lastname: Ji
authors.forename: Rayna M
authors.initials: RM
authors.lastname: Bauzo
authors.forename: Jon C
authors.initials: JC
authors.lastname: Alexander
authors.forename: Adrie W
authors.initials: AW
authors.lastname: Bruijnzeel
mesh_terms: D000818:Animals; D058999:Drug-Seeking Behavior / Q000187:drug effects / Q000502:physiology*; D009538:Nicotine / Q000008:administration & dosage* / Q000009:adverse effects; D018722:Nicotinic Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D010456:Peptides, Cyclic / Q000494:pharmacology; D051381:Rats; D044105:Receptor, Melanocortin, Type 4 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012008:Recurrence; D013315:Stress, Psychological / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000378:metabolism*; D014029:Tobacco Use Disorder / Q000378:metabolism*
chemical_list: C116098:HS 024; C116941:HS014 cyclic peptide; D018722:Nicotinic Agonists; D010456:Peptides, Cyclic; D044105:Receptor, Melanocortin, Type 4; D009538:Nicotine
keywords: Dysphoria; ICSS; MC4 receptor; nicotine; rats; stress-induced reinstatement